Jubilant Pharmova's Stock Reaches All-Time High, Receives 'Strong Buy' Rating

Nov 03 2024 09:20 AM IST
share
Share Via
Jubilant Pharmova, a leading pharmaceutical company, has reached an all-time high in its stock price on November 3rd, 2024. According to MarketsMojo, the stock has been given a 'Strong Buy' rating and has shown consecutive gains for the past four days. The stock's impressive performance and high volatility reflect the company's strong growth and potential for future success.


Jubilant Pharmova, a leading pharmaceutical company in the largecap industry, has reached an all-time high in its stock price on November 3rd, 2024. This news comes as a positive development for investors and the company alike.

According to MarketsMOJO, a trusted source for stock analysis and recommendations, Jubilant Pharmova's stock has been given a 'Strong Buy' rating. The company has also been listed as a Reliable Performer on MarketsMOJO since October 31st, 2024.

The stock's performance today has been impressive, outperforming the sector by 3.85%. It has also shown consecutive gains for the past four days, with a 15.57% increase in returns during this period. The stock's intraday high of Rs. 1277 marks a 4.63% increase, showcasing its strong performance.

Jubilant Pharmova's stock has also been highly volatile today, with an intraday volatility of 6.27%. However, this is not uncommon for a company that is experiencing such a significant increase in its stock price.

In addition, the company's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock and further reinforces its strong performance.

In the past year, Jubilant Pharmova's stock has shown an impressive 239.92% increase, outperforming the Sensex's performance of 25.37%. This showcases the company's strong growth and potential for future success.

Overall, Jubilant Pharmova's stock reaching an all-time high is a testament to the company's success and growth in the pharmaceutical industry. With a 'Strong Buy' rating and a spot on the list of Reliable Performers, the company is poised for continued success in the future.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
Why is Vishal Mega Mart falling/rising?
58 minutes ago
share
Share Via
Why is Purple United falling/rising?
58 minutes ago
share
Share Via
Why is Waaree Energies falling/rising?
58 minutes ago
share
Share Via
Why is Gala Precis. Eng falling/rising?
59 minutes ago
share
Share Via
Why is Motherson Wiring falling/rising?
59 minutes ago
share
Share Via
Why is DCX Systems falling/rising?
59 minutes ago
share
Share Via
Why is Jana Small Finan falling/rising?
59 minutes ago
share
Share Via